Trials that use: P-values
New to this method? Read the tutorial →
10,201 results
- Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ALLIndependent statistical analysis of Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- All in Dads! Healthy Marriage and Responsible Fatherhood Program Evaluation: Complete Statistical AnalysisIndependent statistical analysis of All in Dads! Healthy Marriage and Responsible Fatherhood Program Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05194020).
- ALLAYIndependent statistical analysis of Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension: primary endpoint results, effect estimate with confidence…
- ALLAY-LID-IIndependent statistical analysis of Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ALLEGRO-2b/3Independent statistical analysis of PF-06651600 for the Treatment of Alopecia Areata: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03732807).
- AllianceIndependent statistical analysis of Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults: primary endpoint results, effect estimate with confidence…
- Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs: Complete Statistical AnalysisIndependent statistical analysis of Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs: primary endpoint results, effect estimate with confidence interval, sample-size…
- Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3): Complete Statistical AnalysisIndependent statistical analysis of Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Allogeneic Stem Cell Transplant for CLL: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic Stem Cell Transplant for CLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01629511).
- AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders: Complete Statistical AnalysisIndependent statistical analysis of AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides: Complete Statistical AnalysisIndependent statistical analysis of Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ALPACSIndependent statistical analysis of Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00728988).
- Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ALPHA Sitagliptin Add on to Metformin (0431-103): Complete Statistical AnalysisIndependent statistical analysis of ALPHA Sitagliptin Add on to Metformin (0431-103): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00833027).
- Alpha-1 Carrier Genomics Study: Complete Statistical AnalysisIndependent statistical analysis of Alpha-1 Carrier Genomics Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02810327).
- ALTA-3Independent statistical analysis of A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Altering Activation Patterns Post-stroke: Complete Statistical AnalysisIndependent statistical analysis of Altering Activation Patterns Post-stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02418949).
- Alternative EndoCrowns Designs for Chairside CAD/CAM: Complete Statistical AnalysisIndependent statistical analysis of Alternative EndoCrowns Designs for Chairside CAD/CAM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04604314).
- ALTISSIMOIndependent statistical analysis of A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AltoidaMLIndependent statistical analysis of Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AMADIndependent statistical analysis of Efficacy of Acupuncture in Macular Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02255981).
- Amara View Benchmark Study: Complete Statistical AnalysisIndependent statistical analysis of Amara View Benchmark Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06535932).
- AMARANTHComplete statistical analysis of the AMARANTH phase 2/3 trial of lanabecestat in early Alzheimer's disease, including trial design, primary and secondary endpoint results, ANCOVA and mixed-effects methodology, safety, and statistical interpretation.
- AmatuximabIndependent statistical analysis of An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AMAZEIndependent statistical analysis of Cohort 2 (Abdominoplasty) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06109428).
- AMBER IIIndependent statistical analysis of A Open Label Study to Assess the Long-term Safety, Tolerability and Efficacy of Ambrisentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH): primary endpoint results, effect estimate…
- ambrisentanIndependent statistical analysis of Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AMEERA-3Independent statistical analysis of Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- AMETHYSTIndependent statistical analysis of Study of Verinurad in Heart Failure With Preserved Ejection Fraction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04327024).
- AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate…
- AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- AMILORIndependent statistical analysis of Amiloride in Nephrotic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05079789).
- Aminotransferase Trends During Prolonged Acetaminophen Dosing: Complete Statistical AnalysisIndependent statistical analysis of Aminotransferase Trends During Prolonged Acetaminophen Dosing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00743093).
- Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04790279).
- Amnion-Chorion Allograft Barrier Used for Root Surface and Guided Tissue Regeneration: Complete Statistical AnalysisIndependent statistical analysis of Amnion-Chorion Allograft Barrier Used for Root Surface and Guided Tissue Regeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia: Complete Statistical AnalysisIndependent statistical analysis of Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AMPACT1Independent statistical analysis of AM-101 in the Treatment of Post-Acute Tinnitus 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01934010).
- Amplatzer Amulet China Post Market Study (PMS): Complete Statistical AnalysisIndependent statistical analysis of Amplatzer Amulet China Post Market Study (PMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06189365).
- AMPLIFY-201Independent statistical analysis of A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- AMPLITUDE-OIndependent statistical analysis of the phase 3 AMPLITUDE-O trial of efpeglenatide in people with type 2 diabetes, including randomized design, time-to-event endpoints, non-inferiority and superiority analyses, hazard ratios, confidence intervals, and statistical…
- AMPSIndependent statistical analysis of Alcohol & Mobile Phone Study to Reduce High-risk Alcohol Use and Consequences: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment: Complete Statistical AnalysisIndependent statistical analysis of Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02317783).
- An 8 Week Open-Label Study to Evaluate the Efficacy and Safety of Acamprosate Calcium (Campral) as Augmentation Therapy in Patients With Anxiety Symptoms Who Are Only Partial Responders to SSRI or SNRI Antidepressants: Complete Statistical AnalysisIndependent statistical analysis of An 8 Week Open-Label Study to Evaluate the Efficacy and Safety of Acamprosate Calcium (Campral) as Augmentation Therapy in Patients With Anxiety Symptoms Who Are Only Partial Responders…